Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1.

Abstract

Increased kynurenine pathway metabolism has been implicated in the aetiology of the AIDS dementia complex (ADC). The rate limiting enzyme for this pathway is indoleamine 2,3-dioxygenase (IDO). We tested the efficacy of different strains of HIV-1 (HIV1-BaL, HIV1-JRFL and HIV1-631) to induce IDO in cultured human monocyte-derived macrophages (MDM). A significant increase in both IDO protein and kynurenine synthesis was observed after 48 h in MDM infected with the brain derived HIV-1 isolates, laboratory adapted (LA) HIV1-JRFL, and primary isolate HIV1-631. In contrast, almost no kynurenine production or IDO protein was evident in MDM infected with the high replicating macrophage tropic LA strain, HIV1-BaL. The induction of IDO and kynurenine synthesis by HIV1-JRFL and HIV1-631 declined to baseline levels by day-8 post-infection. Together, these results indicate that only selected strains of HIV-1 are capable of inducing IDO synthesis and subsequent oxidative tryptophan catabolism in MDM.

Statistics

050'03'05'07'09'11'13'15'17
Citations per Year

198 Citations

Semantic Scholar estimates that this publication has 198 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Grant2000InductionOI, title={Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1.}, author={Ross Grant and Hassan M. Naif and Sophy J Thuruthyil and Najla Nasr and Tamantha K Littlejohn and Osamu Takikawa and Vishal Kapoor}, journal={Redox report : communications in free radical research}, year={2000}, volume={5 2-3}, pages={105-7} }